Remote Preconditioning and Myocardial Protection

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Congenital Heart Disease
Interventions
DRUG

Sevoflurane plus remote ischemic preconditioning

Inhalational anesthesia (Sevoflurane) in addition to remote ischemic preconditioning

DRUG

Total intravenous anesthesia plus remote ischemic preconditioning

Total intravenous anesthesia (propofol plus fentanyl) in addition to remote ischemic preconditioning

Trial Locations (1)

Unknown

Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02877238 - Remote Preconditioning and Myocardial Protection | Biotech Hunter | Biotech Hunter